We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,884
Increased
5,796
Reduced
5,769
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Consumer Discretionary 2.25%
3 Healthcare 2.2%
4 Financials 2.18%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPWRW
13376
SunPower Inc Warrants
SPWRW
$538K
$39K ﹤0.01%
+57,569
New +$53.8K
CPARW
13377
DELISTED
Catalyst Partners Acquisition Corp. Warrant
CPARW
$39K ﹤0.01%
+45,524
New +$54.5K
SWETW
13378
DELISTED
Athlon Acquisition Corp. Warrant
SWETW
$39K ﹤0.01%
56,208
-243,750
-81% -$182K
LEJU
13379
CALL
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
$39K ﹤0.01%
3,460
+2,320
+204% +$35.6K
CHNR icon
13380
China Natural Resources
CHNR
$4.55M
$38K ﹤0.01%
+767
New +$42K
MRKR icon
13381
Marker Therapeutics
MRKR
$18.8M
$38K ﹤0.01%
2,267
-27,036
-92% -$554K
PHUN icon
13382
Phunware
PHUN
$43.1M
$38K ﹤0.01%
825
-99
-11% -$5.26K
TRIB
13383
Trinity Biotech
TRIB
$7.83M
$38K ﹤0.01%
118
-15
-11% -$5.28K
XCUR icon
13384
Exicure
XCUR
$10.2M
$38K ﹤0.01%
211
+29
+16% +$5.88K
ZKIN icon
13385
ZK International Group
ZKIN
$77.4M
$38K ﹤0.01%
1,931
-13,390
-87% -$317K
SER icon
13386
Serina Therapeutics
SER
$30M
$38K ﹤0.01%
+1,153
New +$48.4K
JXG
13387
JX Luxventure
JXG
$38K ﹤0.01%
22
-10
-31% -$22.2K
TRVN
13388
DELISTED
Trevena, Inc.
TRVN
$38K ﹤0.01%
49
-171
-78% -$145K
ORTX
13389
CALL
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$38K ﹤0.01%
+1,650
New +$49.1K
IDEX
13390
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$38K ﹤0.01%
+155
New +$45.2K
ASAXW
13391
DELISTED
Astrea Acquisition Corp. Warrant
ASAXW
$38K ﹤0.01%
48,758
-100,000
-67% -$63K
AXU
13392
CALL
DELISTED
Alexco Resource Corp
AXU
$38K ﹤0.01%
25,200
-7,100
-22% -$13.6K
AACG
13393
ATA Creativity
AACG
$39.3M
$37K ﹤0.01%
15,863
-1,056
-6% -$2.98K
LCTX icon
13394
PUT
Lineage Cell Therapeutics
LCTX
$269M
$37K ﹤0.01%
14,800
-27,800
-65% -$71.3K
LQDA icon
13395
Liquidia Corp
LQDA
$7.48B
$37K ﹤0.01%
13,597
-23,745
-64% -$61.7K
SDEV
13396
Stablecoin Development Corp
SDEV
$58M
$37K ﹤0.01%
9
-6
-40% -$23.1K
PVL
13397
CALL
Permianville Royalty Trust
PVL
$57.1M
$37K ﹤0.01%
19,200
-2,900
-13% -$5.35K
YCBD icon
13398
cbdMD
YCBD
$5.32M
$37K ﹤0.01%
50
-16
-24% -$13.4K
LFWD icon
13399
CALL
ReWalk Robotics
LFWD
$20.3M
$37K ﹤0.01%
292
-802
-73% -$99.6K
BTCY
13400
DELISTED
Biotricity, Inc. Common Stock
BTCY
$37K ﹤0.01%
+2,074
New +$38.9K

Similar funds

Citadel Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Citadel Advisors held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citadel Advisors deployed $38.1B of net new capital in Q3 2021, opening 1,884 new positions and adding to 5,796 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Citadel Advisors's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Citadel Advisors added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Citadel Advisors's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Citadel Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Citadel Advisors's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Citadel Advisors opened 1,884 new positions and closed 1,724 in Q3 2021.
  • Citadel Advisors's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.